Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06034327 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens

Study acronym: EUCALYPTUS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jan 31, 2026 to Jan 31, 2027
    • Study completion date: Mar 31, 2026 to Mar 31, 2027
    v5
  2. Primary completion date: Apr 30, 2025 to Jan 31, 2026
    • Study completion date: Jun 30, 2025 to Mar 31, 2026
    v4
  3. Study sites: 4 to 14v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 30, 2023 to Sep 18, 2023
    • Site details revised at 4 of 4 sites
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will be used to predict the 3-year treatment efficacy. This is a randomized, controlled (1:1), multisite, subject- and observer-masked, 2-arm parallel group study.
Trial Details
NCT Number NCT06034327
Lead Sponsor SightGlass Vision, Inc.
Conditions
(from sponsor)		 Myopia, Juvenile Myopia, Myopia Progression
Related terms Myopia
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov